| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 360 | $90 | $34K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 430 | $70 | $27.9K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 150 | $110 | $15.3K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $280 | $6.8K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 60 | $80 | $4.9K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 30 | $140 | $4K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 500 | $10 | $4K |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 20 | $140 | $2.4K |
| G0008 | Administration of influenza virus vaccine | 70 | $30 | $1.7K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 30 | $50 | $1.4K |